Organon Financial Statements (OGN)
|
|
Report date
|
|
|
03.11.2023 |
26.02.2024 |
03.05.2024 |
07.08.2024 |
01.11.2024 |
|
01.11.2024 |
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
1 519 |
1 598 |
1 622 |
1 607 |
1 582 |
|
6 409 |
Operating Income, bln rub |
|
|
0.232 |
312.0 |
414.0 |
386.0 |
390.0 |
|
1 502 |
EBITDA, bln rub |
? |
|
293.0 |
374.0 |
479.0 |
432.0 |
402.0 |
|
1 687 |
Net profit, bln rub |
? |
|
58.0 |
546.0 |
201.0 |
195.0 |
359.0 |
|
1 301 |
|
OCF, bln rub |
? |
|
261.0 |
397.0 |
76.0 |
332.0 |
-407.5 |
|
397.5 |
CAPEX, bln rub |
? |
|
55.0 |
81.0 |
46.0 |
47.0 |
92.9 |
|
266.9 |
FCF, bln rub |
? |
|
206.0 |
316.0 |
30.0 |
285.0 |
-314.6 |
|
316.4 |
Dividend payout, bln rub
|
|
|
74.0 |
73.0 |
70.0 |
79.0 |
74.0 |
|
296.0 |
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
Dividend payout ratio, %
|
|
|
127.6% |
13.4% |
34.8% |
40.5% |
20.6% |
|
22.8% |
|
OPEX, bln rub |
|
|
675.0 |
603.0 |
543.0 |
553.0 |
533.0 |
|
2 232 |
Cost of production, bln rub |
|
|
612.0 |
683.0 |
665.0 |
668.0 |
659.0 |
|
2 675 |
R&D, bln rub |
|
|
137.0 |
134.0 |
112.0 |
116.0 |
111.0 |
|
473.0 |
Interest expenses, bln rub |
|
|
134.0 |
129.0 |
131.0 |
131.0 |
126.0 |
|
517.0 |
|
Assets, bln rub |
|
|
11 012 |
12 058 |
11 891 |
12 154 |
12.8 |
|
12.8 |
Net Assets, bln rub |
? |
|
-589.0 |
-70.0 |
48.0 |
144.0 |
493.0 |
|
493.0 |
Debt, bln rub |
|
|
8 654 |
8 760 |
8 714 |
8 656 |
8 749 |
|
8 749 |
Cash, bln rub |
|
|
414.0 |
693.0 |
575.0 |
704.0 |
0.763 |
|
0.763 |
Net debt, bln rub |
|
|
8 240 |
8 067 |
8 139 |
7 952 |
8 748 |
|
8 748 |
|
Ordinary share price, rub |
|
|
17.4 |
14.4 |
18.8 |
20.7 |
19.1 |
|
30.5 |
Number of ordinary shares, mln |
|
|
255.6 |
255.6 |
255.7 |
257.3 |
257.5 |
|
257.5 |
|
Market cap, bln rub |
|
|
4 437 |
3 686 |
4 807 |
5 326 |
4 926 |
|
7 854 |
EV, bln rub |
? |
|
12 677 |
11 753 |
12 946 |
13 278 |
13 674 |
|
16 602 |
Book value, bln rub |
|
|
-5 753 |
-5 206 |
-5 273 |
-5 143 |
488 |
|
488 |
|
EPS, rub |
? |
|
0.23 |
2.14 |
0.79 |
0.76 |
1.39 |
|
5.05 |
FCF/share, rub |
|
|
0.81 |
1.24 |
0.12 |
1.11 |
-1.22 |
|
1.23 |
BV/share, rub |
|
|
-22.5 |
-20.4 |
-20.6 |
-20.0 |
1.89 |
|
1.89 |
|
EBITDA margin, % |
? |
|
19.3% |
23.4% |
29.5% |
26.9% |
25.4% |
|
26.3% |
Net margin, % |
? |
|
3.82% |
34.2% |
12.4% |
12.1% |
22.7% |
|
20.3% |
FCF yield, % |
? |
|
9.56% |
14.6% |
10.6% |
15.7% |
6.42% |
|
4.03% |
ROE, % |
? |
|
-99.3% |
-1 461% |
2 181% |
694.4% |
263.9% |
|
263.9% |
ROA, % |
? |
|
5.31% |
8.48% |
8.80% |
8.23% |
10 202% |
|
10 202% |
|
P/E |
? |
|
7.58 |
3.60 |
4.59 |
5.33 |
3.79 |
|
6.04 |
P/FCF |
|
|
10.5 |
6.85 |
9.46 |
6.36 |
15.6 |
|
24.8 |
P/S |
? |
|
0.72 |
0.59 |
0.76 |
0.84 |
0.77 |
|
1.23 |
P/BV |
? |
|
-0.77 |
-0.71 |
-0.91 |
-1.04 |
10.1 |
|
16.1 |
EV/EBITDA |
? |
|
9.40 |
8.14 |
8.44 |
8.41 |
8.11 |
|
9.84 |
Debt/EBITDA |
|
|
6.11 |
5.59 |
5.31 |
5.04 |
5.19 |
|
5.19 |
|
R&D/CAPEX, % |
|
|
249.1% |
165.4% |
243.5% |
246.8% |
119.5% |
|
177.2% |
|
CAPEX/Revenue, % |
|
|
3.62% |
5.07% |
2.84% |
2.92% |
5.87% |
|
4.16% |
|
Organon shareholders |